Skip to main content
Earnings Labs
Organon & Co. logo

Organon & Co. (OGN)

NYSE·Healthcare·Drug Manufacturers - General

$13.75

—

Mkt Cap $3.61B

Analyst Ratings

No recent rating data.

Price Target (9 analysts)

$13.00

Range $12.00 – $14.00

Implied Upside

-5.5%

Consensus $13.00 vs current $13.75